查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1402014

2030 年合成生物學市場預測：按產品、技術、應用、最終用戶和地區進行的全球分析

Synthetic Biology Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球合成生物學市場規模為 155 億美元，預計在預測期內複合年成長率為 19%，到 2030 年將達到 526 億美元。

合成生物學是生物學的一個先進領域，它利用現代科學來改造生物體，以改善醫療衛生服務的發展。其用途多種多樣，包括細胞訊號傳導、疫苗開發和抗體生產。這個過程涉及確定治療各種疾病（包括感染疾病、免疫學和癌症疾病）的新治療標靶所需的特定代謝途徑。

根據 SynBioBeta資料，合成生物學新興企業在 2021 年籌集了 180 億美元。

擴大合成生物技術的應用

病原體、污染和氣候危機造成的威脅日益嚴重，合成生物學研究和開發的資金不斷增加。多個行業擴大採用合成生物學，旨在減少碳排放，防止全球氣溫進一步升高。這是因為該技術可以重現基本化學品和材料的特性，而不會對環境產生負面影響。因此，合成生物學的研究和開發變得更加活躍，其不斷擴大的應用範圍正在推動市場。

生物安全問題

有意或無意地將合成生物體釋放到環境中（例如出於科學目的）是合成生物學中的主要生物安全風險。當合成微生物被引入大氣中時，它們可能會突變並與現有物種相互作用，從而導致雜交和生物錯誤。這些後果可能會使野生動物棲息地面臨風險。此外，對抗生素具有抗藥性的病毒的出現對生物安全構成了嚴重威脅。這些限制可能會阻礙未來幾年的市場擴張。

擴大醫療應用

在藥物研發中，合成生物學透過自訂製化生物電路加速治療化合物的識別和開發。這不僅提高了藥物開發的效率，也為創造更有效、更有針對性的藥物鋪平了道路。此外，合成生物學在生物製藥的生產中發揮重要作用，使得工程利用微生物合成治療性蛋白質和疫苗成為可能。這些不斷成長的醫學應用正在推動市場需求。

有限的可預測性

合成生物體和工程生物電路的行為通常是不可預測的，這給研究人員和開發人員帶來了挑戰。生物成分之間複雜的相互作用可能會導致意想不到的後果，例如出現意外行為或合成系統無法如預期發揮作用。然而，這種可預測性的缺乏阻礙了合成生物系統的有效設計和最佳化，導致時間和資源密集的試驗誤方法。因此，有限的可預測性是阻礙市場成長的關鍵因素。

COVID-19 的影響

在 COVID-19大流行期間，由於產量減少、停工和勞動力短缺，合成生物市場最初經歷了成長略有放緩。然而，由於對 COVID-19 管理的新型療法、疫苗和診斷方法的需求不斷增加，該市場最終再次成長。藥物開發和新冠疫苗研究支持了合成​​生物學研究。

底盤生物部分預計將在預測期內成為最大的部分

底盤生物部分估計佔最大佔有率。這些底盤生物提供了一個重要的生物框架，用於整合遺傳電路和組件，以創造新的功能和改進的生物過程。諸如大腸桿菌的細菌和諸如釀酒酵母的酵母是經常使用的底盤生物體。選擇這些生物體是因為它們的遺傳背景易於理解、易於操作以及已建立的基因工程工具。底盤生物學領域的核心思想驅動著合成生物學的創新與發展。

PCR 技術領域預計在預測期內複合年成長率最高。

PCR 技術領域預計將在預測期內出現良好的成長。聚合酶鍊式反應（PCR）已發展成為檢測和分析特定基因序列的重要技術。對於大多數基於 PCR 的基因組研究，即時 PCR 檢測因其卓越的靈敏度和特異性而成為首選方法。這種方法通常用於法醫學分析、分子診斷、DNA 克隆和基因組學。

佔有率最大的地區

在估計期間，北美佔據了最大的市場佔有率。世界上大多數在藥物開發過程中使用合成生物學的公司和學術機構都位於北美。該地區運算能力、人工智慧和基因組圖譜的進步使研究人員能夠快速採用新技術並根據現有概念創建新功能。此外，數千名研究人員、科學家、學術機構、政府部門、私人投資者和產品工程師的合作正在透過新發現推動該地區的市場向前發展。

複合年成長率最高的地區：

預計亞太地區在預測期內將實現盈利成長。亞太地區投資的增加、中國市場的資金和合作夥伴關係的增加以及合成生物學領域合作的加強是預計推動市場成長的一些因素。此外，亞洲將在合成生物學應用開發新療法方面發揮重要作用。亞洲各國政府和私人投資者對合成生物學研究和技術轉移越來越感興趣，該領域對於培育永續的生物經濟有著巨大的前景。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球合成生物市場：依產品

  • 介紹
  • 寡核苷酸
  • 酵素
  • 克隆技術套件
  • 合成DNA
  • 底盤生物學
  • 合成細胞
  • 異源核酸
  • 合成克隆
  • 其他產品

第6章全球合成生物市場：依技術分類

  • 介紹
  • 定點特異性
  • 奈米科技
  • 基因合成
  • 生物資訊學
  • 測量和建模
  • 基因組工程
  • 順序
  • 新一代定序技術
  • 生物加工
  • 複製
  • PCR技術
  • 微流體學
  • 其他技術

第7章全球合成生物市場：依應用分類

  • 介紹
  • 醫學
    • 藥物研發與治療
    • 藥品
    • 人工組織和組織再生
  • 環境應用
    • 生物感
    • 生物修復
  • 工業用途
    • 工業酵素
    • 生物燃料和可再生能源
    • 生物材料和生態化學品
  • 在食品和農業的應用
    • 香精香料
  • 其他用途

第8章全球合成生物市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 生物技術和製藥業
  • 其他最終用戶

第9章全球合成生物市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Synbio Technologies
  • GenScript
  • Agilent Technologies, Inc.
  • Eurofins Genomics GmbH
  • Thermo Fisher Scientific
  • Amyris
  • Merck KGaA
  • Codexis, Inc.
  • Integrated DNA Technologies, Inc.
  • Synthego
  • EnBiotix, Inc.
  • Genomatica, Inc.
  • 新英格蘭生物實驗室（英國）有限公司
  • Scarab Genomics, LLC
Product Code: SMRC24534

According to Stratistics MRC, the Global Synthetic Biology Market is accounted for $15.5 billion in 2023 and is expected to reach $52.6 billion by 2030 growing at a CAGR of 19% during the forecast period. Synthetic biology is an advanced field of biology that uses modern science to engineer organisms in order to improve the development of medical and health services. Its applications vary and include cellular signalling, vaccine development, and antibody production. The process includes specific metabolic pathways that are necessary for identifying novel therapeutic targets for the treatment of a variety of illnesses, including infectious, immunological, and cancerous diseases.

According to SynBioBeta data, startups within the synthetic biology sector raised 18.0 billion in 2021.

Market Dynamics:

Driver:

Rising applications of synthetic biotechnology

The funding for synthetic biology research and development has increased due to the growing threat posed by pathogens, pollution, and the climate change crisis. The adoption of synthetic biology has increased in several industries that aim to lower their carbon footprints in order to prevent further rises in global temperatures. This is due to the technology's ability to replicate the properties of essential chemicals and materials without causing negative environmental effects. Therefore, rising research and development in synthetic biology are widening the scope of its applications, which will drive the market.

Restraint:

Bio safety concerns

The intentional or unintentional release of synthetic organisms into the environment for scientific purposes or other purposes poses the main bio safety risk in synthetic biology. When synthetic microorganisms are put into the atmosphere, they can mutate or interact with existing species, resulting in crossbreeding and bio errors. These consequences may endanger the habitats of wild animals. Moreover, a serious threat to bio security is the emergence of viruses that are resistant to antibiotics. These limitations could hamper market expansion in the coming years.

Opportunity:

Expanding applications in healthcare

In drug discovery, synthetic biology accelerates the identification and development of therapeutic compounds by constructing custom biological circuits. This not only enhances the efficiency of drug development but also opens avenues for the creation of more effective and targeted pharmaceuticals. Additionally, synthetic biology plays a crucial role in biopharmaceutical production, enabling the engineering of microorganisms for the synthesis of therapeutic proteins and vaccines. These rising applications in healthcare propel market demand.

Threat:

Limited predictability

The behavior of synthetic organisms and engineered biological circuits often exhibits unpredictability, posing challenges for researchers and developers. The complex interplay of biological components can result in unintended consequences, such as the emergence of unexpected behaviours or the failure of synthetic systems to perform as intended. However, this lack of predictability hinders the efficient design and optimization of synthetic biological systems, leading to time-consuming and resource-intensive trial-and-error approaches. Therefore, limited predictability is a significant element hampering market growth.

COVID-19 Impact

The synthetic biology market saw a minor downturn in growth during the COVID-19 pandemic, at first because of a decrease in production, then lockdown and a labor shortage. However, the market eventually saw resurgence in growth because of the increased need for novel treatments, vaccines, and diagnostics for COVID-19 management. The development of medications and research on the COVID vaccine supported synthetic biology research.

The chassis organism segment is expected to be the largest during the forecast period

The chassis organism segment is estimated to hold the largest share. These chassis organisms provide the essential biological framework onto which genetic circuits and components can be integrated to create novel functionalities or modified biological processes. Bacteria like Escherichia coli and yeasts like Saccharomyces cerevisiae are frequently used chassis organisms. These organisms are selected for their well-understood genetic backgrounds, ease of manipulation, and established tools for genetic engineering. The field's core idea of chassis organisms promotes innovation and developments in synthetic biology.

The PCR technology segment is expected to have the highest CAGR during the forecast period

The PCR technology segment is anticipated to have lucrative growth during the forecast period. Polymerase Chain Reaction (PCR) has evolved as a crucial technology for detecting and analyzing specific gene sequences. For most PCR-based genomic research, real-time PCR tests are the preferred approach due to their exceptional sensitivity and specificity. This approach is commonly utilized in forensic analysis, molecular diagnostics, DNA cloning, and genomics.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The majority of the world's businesses and academic institutions that use synthetic biology in their drug development processes are located in North America. Advances in computer power, artificial intelligence, and genome mapping in this region have prompted researchers to quickly embrace new methods and build upon pre-existing concepts to create new capacities. Additionally, the cooperation of thousands of researchers, scientists, academic institutions, government departments, private investors, and product engineers has advanced the market in this region with new discoveries.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. Increasing investments in the Asia-Pacific region, more funding and partnerships in the Chinese market, and more collaboration in the field of synthetic biology are some of the factors anticipated to propel market growth. Additionally, Asia is also well-positioned to play a significant role in the application of synthetic biology toward the development of novel therapeutics. Governments and private investors in Asia are becoming increasingly interested in synthetic biology research and technology translation, where the field holds enormous promise for fostering a sustainable bio-based economy.

Key players in the market:

Some of the key players in the Synthetic Biology Market include Synbio Technologies, GenScript, Agilent Technologies, Inc., Eurofins Genomics GmbH, Thermo Fisher Scientific, Amyris, Merck KGaA, Codexis, Inc., Integrated DNA Technologies, Inc., Synthego, EnBiotix, Inc., Genomatica, Inc., New England Biolabs (UK) Ltd. and Scarab Genomics, LLC.

Key Developments:

In April 2022, Merck KGaA Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System. The acquisition of the MAST platform is another milestone to accelerate innovation in Merck's Process Solutions business unit.

In February 2022, Thermo Fisher Scientific announced the launch of GeneMapper Software, a flexible genotyping software package that provides DNA sizing and quality allele calls for all Thermo Fisher Scientific electrophoresis-based genotyping.

Products Covered:

  • Oligonucleotide
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic DNA
  • Chassis Organism
  • Synthetic cells
  • Xeno-Nucleic Acids
  • Synthetic Clones
  • Other Products

Technologies Covered:

  • Site-Directed Mutagenesis
  • Nanotechnology
  • Gene Synthesis
  • Bioinformatics
  • Measurement and Modelling
  • Genome Engineering
  • Sequencing
  • NGS Technology
  • Bio processing
  • Cloning
  • PCR Technology
  • Microfluidics
  • Other Technologies

Applications Covered:

  • Medical
  • Environmental Applications
  • Industrial Applications
  • Food and Agricultural Applications
  • Other Applications

End Users Covered:

  • Academics & Research Institutes
  • Biotechnology & Pharmaceutical Industry
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Synthetic Biology Market, By Product

  • 5.1 Introduction
  • 5.2 Oligonucleotide
  • 5.3 Enzymes
  • 5.4 Cloning Technologies Kits
  • 5.5 Synthetic DNA
  • 5.6 Chassis Organism
  • 5.7 Synthetic cells
  • 5.8 Xeno-Nucleic Acids
  • 5.9 Synthetic Clones
  • 5.10 Other Products

6 Global Synthetic Biology Market, By Technology

  • 6.1 Introduction
  • 6.2 Site-Directed Mutagenesis
  • 6.3 Nanotechnology
  • 6.4 Gene Synthesis
  • 6.5 Bioinformatics
  • 6.6 Measurement and Modelling
  • 6.7 Genome Engineering
  • 6.8 Sequencing
  • 6.9 NGS Technology
  • 6.10 Bioprocessing
  • 6.11 Cloning
  • 6.12 PCR Technology
  • 6.13 Microfluidics
  • 6.14 Other Technologies

7 Global Synthetic Biology Market, By Application

  • 7.1 Introduction
  • 7.2 Medical
    • 7.2.1 Drug Discovery and Therapeutics
    • 7.2.2 Pharmaceuticals
    • 7.2.3 Artificial Tissue and Tissue Regeneration
  • 7.3 Environmental Applications
    • 7.3.1 Biosensing
    • 7.3.2 Bioremediation
  • 7.4 Industrial Applications
    • 7.4.1 Industrial Enzymes
    • 7.4.2 Biofuel and Renewable Energy
    • 7.4.3 Biomaterials and Green Chemicals
  • 7.5 Food and Agricultural Applications
    • 7.5.1 Flavors and Fragrances
  • 7.6 Other Applications

8 Global Synthetic Biology Market, By End user

  • 8.1 Introduction
  • 8.2 Academics & Research Institutes
  • 8.3 Biotechnology & Pharmaceutical Industry
  • 8.4 Other End Users

9 Global Synthetic Biology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Synbio Technologies
  • 11.2 GenScript
  • 11.3 Agilent Technologies, Inc.
  • 11.4 Eurofins Genomics GmbH
  • 11.5 Thermo Fisher Scientific
  • 11.6 Amyris
  • 11.7 Merck KGaA
  • 11.8 Codexis, Inc.
  • 11.9 Integrated DNA Technologies, Inc.
  • 11.10 Synthego
  • 11.11 EnBiotix, Inc.
  • 11.12 Genomatica, Inc.
  • 11.13 New England Biolabs (UK) Ltd.
  • 11.14 Scarab Genomics, LLC

List of Tables

  • Table 1 Global Synthetic Biology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Synthetic Biology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Synthetic Biology Market Outlook, By Oligonucleotide (2021-2030) ($MN)
  • Table 4 Global Synthetic Biology Market Outlook, By Enzymes (2021-2030) ($MN)
  • Table 5 Global Synthetic Biology Market Outlook, By Cloning Technologies Kits (2021-2030) ($MN)
  • Table 6 Global Synthetic Biology Market Outlook, By Synthetic DNA (2021-2030) ($MN)
  • Table 7 Global Synthetic Biology Market Outlook, By Chassis Organism (2021-2030) ($MN)
  • Table 8 Global Synthetic Biology Market Outlook, By Synthetic cells (2021-2030) ($MN)
  • Table 9 Global Synthetic Biology Market Outlook, By Xeno-Nucleic Acids (2021-2030) ($MN)
  • Table 10 Global Synthetic Biology Market Outlook, By Synthetic Clones (2021-2030) ($MN)
  • Table 11 Global Synthetic Biology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Synthetic Biology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global Synthetic Biology Market Outlook, By Site-Directed Mutagenesis (2021-2030) ($MN)
  • Table 14 Global Synthetic Biology Market Outlook, By Nanotechnology (2021-2030) ($MN)
  • Table 15 Global Synthetic Biology Market Outlook, By Gene Synthesis (2021-2030) ($MN)
  • Table 16 Global Synthetic Biology Market Outlook, By Bioinformatics (2021-2030) ($MN)
  • Table 17 Global Synthetic Biology Market Outlook, By Measurement and Modelling (2021-2030) ($MN)
  • Table 18 Global Synthetic Biology Market Outlook, By Genome Engineering (2021-2030) ($MN)
  • Table 19 Global Synthetic Biology Market Outlook, By Sequencing (2021-2030) ($MN)
  • Table 20 Global Synthetic Biology Market Outlook, By NGS Technology (2021-2030) ($MN)
  • Table 21 Global Synthetic Biology Market Outlook, By Bioprocessing (2021-2030) ($MN)
  • Table 22 Global Synthetic Biology Market Outlook, By Cloning (2021-2030) ($MN)
  • Table 23 Global Synthetic Biology Market Outlook, By PCR Technology (2021-2030) ($MN)
  • Table 24 Global Synthetic Biology Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 25 Global Synthetic Biology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 26 Global Synthetic Biology Market Outlook, By Application (2021-2030) ($MN)
  • Table 27 Global Synthetic Biology Market Outlook, By Medical (2021-2030) ($MN)
  • Table 28 Global Synthetic Biology Market Outlook, By Drug Discovery and Therapeutics (2021-2030) ($MN)
  • Table 29 Global Synthetic Biology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 30 Global Synthetic Biology Market Outlook, By Artificial Tissue and Tissue Regeneration (2021-2030) ($MN)
  • Table 31 Global Synthetic Biology Market Outlook, By Environmental Applications (2021-2030) ($MN)
  • Table 32 Global Synthetic Biology Market Outlook, By Biosensing (2021-2030) ($MN)
  • Table 33 Global Synthetic Biology Market Outlook, By Bioremediation (2021-2030) ($MN)
  • Table 34 Global Synthetic Biology Market Outlook, By Industrial Applications (2021-2030) ($MN)
  • Table 35 Global Synthetic Biology Market Outlook, By Industrial Enzymes (2021-2030) ($MN)
  • Table 36 Global Synthetic Biology Market Outlook, By Biofuel and Renewable Energy (2021-2030) ($MN)
  • Table 37 Global Synthetic Biology Market Outlook, By Biomaterials and Green Chemicals (2021-2030) ($MN)
  • Table 38 Global Synthetic Biology Market Outlook, By Food and Agricultural Applications (2021-2030) ($MN)
  • Table 39 Global Synthetic Biology Market Outlook, By Flavors and Fragrances (2021-2030) ($MN)
  • Table 40 Global Synthetic Biology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Global Synthetic Biology Market Outlook, By End user (2021-2030) ($MN)
  • Table 42 Global Synthetic Biology Market Outlook, By Academics & Research Institutes (2021-2030) ($MN)
  • Table 43 Global Synthetic Biology Market Outlook, By Biotechnology & Pharmaceutical Industry (2021-2030) ($MN)
  • Table 44 Global Synthetic Biology Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.